KBRYNT
DEAD

Serial Number

79311039

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Mar 18, 2021

Add to watchlist:

No watchlists yet
View on USPTO

KBRYNT Trademark

Serial Number: 79311039 • Registration: 6655807

KBRYNT is a trademark filed by NOVARTIS AG on March 18, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,173 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

March 18, 2021

Registration Date

March 1, 2022

Published for Opposition

December 14, 2021

Cancellation Date

June 9, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jan 6, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jan 6, 2025 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 28, 2022 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Aug 5, 2022 FICS
FINAL DISPOSITION PROCESSED
Aug 5, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 1, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 1, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Dec 19, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 14, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 14, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 24, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 24, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 24, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 5, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 9, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 9, 2021 TROA
REFUSAL PROCESSED BY IB
Jul 31, 2021 RFNT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 9, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 9, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 9, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 9, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 9, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 9, 2021 COAR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 2, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jul 2, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 18, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jun 17, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 2, 2021 DOCK
ASSIGNED TO EXAMINER
May 27, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
May 21, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 17, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 17, 2021 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
May 14, 2021 SDRC